Free Trial
LON:OKYO

OKYO Pharma (OKYO) Share Price, News & Analysis

OKYO Pharma logo

About OKYO Pharma Stock (LON:OKYO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
1.40
1.40
52-Week Range
N/A
Volume
364,142 shs
Average Volume
431,999 shs
Market Capitalization
£23.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Remove Ads
Receive OKYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter.

OKYO Stock News Headlines

Okyo Pharma announces data on long-term stability of urcosimod
Trump… a socialist?
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
Okyo Pharma CEO purchases 10,000 shares of company
See More Headlines

OKYO Stock Analysis - Frequently Asked Questions

Shares of OKYO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that OKYO Pharma investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Aurora Cannabis (ACB) and Allied Gaming & Entertainment (AGAE).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:OKYO
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-6,700,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
28.00
Book Value
GBX (1) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,660,000,000
Free Float
N/A
Market Cap
£23.24 million
Optionable
Not Optionable
Beta
-0.06
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (LON:OKYO) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners